Kazia Therapeutics (KZIA) Return on Invested Capital (2009 - 2011)
Kazia Therapeutics (KZIA) reported Return on Invested Capital of 0.07% for Q4 2011, down 4.0% on a YoY basis from 0.07% in Q4 2010, and down 98.54% quarter-over-quarter from 0.04% in Q4 2010.
Kazia Therapeutics (KZIA) Return on Invested Capital (2009 - 2011) Analysis & Trends
Kazia Therapeutics has reported Return on Invested Capital for 3 years, with the latest figure at 0.07% in Q4 2011.
- For the quarter ending Q4 2011, Return on Invested Capital fell 4.0% year-over-year to 0.07%; the trailing twelve-month figure through Dec 2011 stood at 0.07% (down 4.0% YoY), and the FY2025 full-year result was 0.05%, down 2.0% from the prior year.
- Return on Invested Capital for Q4 2011 stood at 0.07%, down from 0.04% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q4 2009, with the low at 0.07% in Q4 2011.
- Historically, Return on Invested Capital has averaged 0.04% across 3 years, with a median of 0.04% in 2010.
- Annual changes were most pronounced in 2010 — Return on Invested Capital slipped 1 bps — and 2011, when it slipped 4 bps.
- Kazia Therapeutics' Return on Invested Capital stood at 0.02% in 2009, then tumbled by 64 bps to 0.04% in 2010, then slumped by 99 bps to 0.07% in 2011.
- The last three Return on Invested Capital figures came in at 0.07% (Q4 2011), 0.04% (Q4 2010), and 0.02% (Q4 2009), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -0.07% |
| Dec 31, 2010 | -0.04% |
| Dec 31, 2009 | -0.02% |